Qualified Protein degradation is becoming explored instead approach in cancer, whereby the pure protein degradation procedure is co-opted for therapeutic purposes. Just lately designed novel molecules named proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. Just one ligand binds into the ‘protein of curiosity’ https://www.directivepublications.org/journal-of-clinical-breast-cancer/